IMU Biosciences: Funding, Investors & Team (Oct 2026)
IMU is a discovery engine mapping the immune system to advance precision medicine.
IMU Biosciences has raised $53.1M across 2 funding rounds on record, the most recent a Series A of $38.4M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IMU Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2026.
IMU Biosciences Funding Rounds
IMU Biosciences raised $14.7M in a Series A announced in Jan 2024.
2.4 years later, a Series A of $38.4M was announced in Jun 2026.
IMU Biosciences Founders and Leadership Team
Contact details for the IMU Biosciences team: 2 of 2 have an email address on file.
Start 14-day free trial →IMU Biosciences Funding Compared to Other Biotechnology Startups
IMU Biosciences' latest round of $38.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IMU Biosciences in Biotechnology and London
Companies Similar to IMU Biosciences
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU Biosciences Funding FAQs
What does IMU Biosciences do?
IMU is a discovery engine mapping the immune system to advance precision medicine.
How much funding has IMU Biosciences raised?
IMU Biosciences has raised $53.1M across 2 rounds on record. The most recent is a Series A of $38.4M announced in Jun 2026.
When did IMU Biosciences last raise funding?
IMU Biosciences' most recent funding round on record is a Series A of $38.4M, announced in Jun 2026.
Who founded IMU Biosciences?
FundedIQ lists John Baker (Founder), Mario Cantero (Founder) at IMU Biosciences.
Where is IMU Biosciences headquartered?
IMU Biosciences is based in London, England, United Kingdom.
How many employees does IMU Biosciences have?
IMU Biosciences is in the 11-50 employee band.
How does IMU Biosciences' funding compare to other Biotechnology startups?
IMU Biosciences' latest round of $38.4M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's IMU Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IMU Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.